Synonyms Cell Myeloma, Plasma, Cell Myelomas, Plasma, Disease, Kahler + [86] |
Introduction A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. |
Target |
Mechanism BCMA modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date23 Feb 2024 |
Target |
Mechanism γ-secretase inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date27 Nov 2023 |
Target |
Mechanism DR4 agonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Nov 2023 |
Start Date16 Nov 2024 |
Sponsor / Collaborator |
Start Date31 Jul 2024 |
Sponsor / Collaborator |
Start Date30 Jul 2024 |
Sponsor / Collaborator |